INB 01
Alternative Names: INB-01Latest Information Update: 18 Nov 2022
At a glance
- Originator ATAI Life Sciences
- Class Neuropsychotherapeutics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Phase I Mental disorders